Influence of Erythropoietin Treatment on Gonadotropic Hormone Levels and Sexual Function in Male Uremic Patients

References

• Bailey GL. The sick kidney and sex. N Engl J Med 1977; 296: 1288–9.
   PubMed Web of Science ®Google Scholar
• Levy NB, Wynbrandt GD. The quality of life on maintenance hemodialysis. Lancet 1975; 1: 1328–30.
   PubMed Web of Science ®Google Scholar
• Rice GG. Hypermenorrhea in the young hemodialysis patient. Am J Obstet Gynecol 1973; 116: 539–43.
   PubMed Web of Science ®Google Scholar
• Wass VJ, Wass JAH, Rees L, Edwards CRW, Ogg CS. Sex hormone changes underlying menstrual disturbances on hemodialysis. Proc Eur Dial Transplant Assoc 1978; 15: 178–85.
   PubMedGoogle Scholar
• Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med 1980; 93: 21–7.
   PubMed Web of Science ®Google Scholar
• Emmanouel DS, Lindheimer MD, Katz AT. Endocrine abnormalities in chronic renal fialure: pathogenetic prin-ciples and clinical implications. Semin Nephrol 1981; 1: 151–75.
   Google Scholar
• Guevara A, Vidt D, Halberg MC, Zorn EM, Pohlman C, Weiland GR. Serum gonadotropin and testosterone levels in uremic males undergoing intermittent dialysis. Metabolism 1969; 18: 1062–6.
   PubMedGoogle Scholar
• Chen JL, Vidt DG, Zorn EM, Halberg MC, Weiland GR. Pituitary leydig cell function in uremic males. J Clin Endocrinol Metab 1970; 31: 14–7.
   PubMed Web of Science ®Google Scholar
• LimVS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomifene citrate. J Clin Endocrinol Metab 1976; 46: 1370–7.
   Google Scholar
• Nagel TC, Freinkel N, Bell RH, Freisem H, Wilber JF, Metzger BE. Gynecomastia, prolactin and other peptide hormones in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab 1973; 36: 428–432.
   PubMed Web of Science ®Google Scholar
• Olgaard K, Hagen C, Mcneilly AS. Pituitary hormones in women with chronic renal failure: the effect of chronic intermittent hemoand peritoneal dialysis. Acta Endocri-nol 1975; 80: 237–46.
   Google Scholar
• Volpe R, Killinger D, Bird C, Clark AF, Friensen H. Idiopathic galactorrhea and mild hypogonadism in a young adult male. Clin Endocrinol 1972; 35: 684–8.
   Google Scholar
• Boyar RM, Hellmann L. Syndrome of benign nodular adrenal hyperplasia associated with feminization and hyperprolactinemia. Ann Intern Med 1974; 80: 389–94.
   PubMed Web of Science ®Google Scholar
• Ramirez G, Bittle PA, Sanders H, Bercu BB. Hypo-thalamic-hypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patient. J Clin Endocrinol Metab 1992; 74: 517–24.
   PubMedGoogle Scholar
• Ramirez G, Bittle PA, Sanders H, Rabb HAA, Bercu BB. The effects of corticotropin and growth hormone releas-ing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin. J Clin Endocrinol Metab 1994; 78: 63–9.
   Google Scholar
• Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anemia of patients main-tained by chronic hemodialysis. Lancet 1986; 2: 1175–8.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, Osterloh III, Kirkpatrick J, Mishra A. The international index of erectile function (IMF): a multidimension scale for assessment of erectile dysfunction. Urology 1997; 49: 822–30.
   PubMed Web of Science ®Google Scholar
• Sargent J, Gotch F, Burah M, Piercy L, Spinozzi N, Schoenfeld P, et al. Urea kinetics: A guide to nutritional management of renal failure. Am J Clin Nutr 1978; 31: 1696–702.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Singer I. Endocrinology and metabolism in uremic and dialysis: A clinical review. Medicine (Baltimore) 1974; 54: 345–76.
   Web of Science ®Google Scholar
• Lim VS, Auletta F, Kathpalia S. Gonadal dysfunction in chronic renal failure: An endocrinologic review. Dial Transplant 1978; 7: 896–907.
   Google Scholar
• Minoni R, Gottardello F, Bordon P, Montini G, Foresta C. Evidence for specific binding and stimulatory effects of recombinant human erythropoietin isolated adult rat leydig cells. Acta Endocrinol 1992; 127: 459–65.
   Google Scholar
• Yammoto Y, Sofikitis N, Miyagawa I. Effects of erythro-poietin, bromocryptin and hydralazine on testicular func-tion in rats with chronic renal failure. Andrologia 1997; 29: 141–4.
   Google Scholar
• Foresta C, Minor R, Bordon P, Mitto D, Montini G, Varotto A. Erythropoietin stimulates testosterone pro-duction in man. J Clin Endocrinol Metab 1994; 78: 753–6.
   PubMed Web of Science ®Google Scholar
• Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol 1989; 31: 1–5.
   Google Scholar
• Schaefer RM, Kokot F, Kuerner B, Zech M, Heidland A. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin. Int J Artif Organs 1989; 12: 445–9.
   Google Scholar
• Mallick NP, Hutchinson A, Paltel M, Harty J. Factors influencing dialysis outcome: the dialysis dose in per-spective. Nephrol Dial Transplant 1998; 143: 152–7.
   Google Scholar
• Bommer J, Delpozo E, Ritz E, Bommer G. Improved sexual function in male hemodialysis patients on bromo-cryptin. Lancet 1979; 2: 496–7.
   PubMed Web of Science ®Google Scholar
• Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemo-dialysis. Am J Kidney Dis 1994; 74: 1010–8.
   Google Scholar